These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 26287490

  • 1. Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates.
    Zhang S, Sun X, Chang W, Dai Y, Ma X.
    PLoS One; 2015; 10(8):e0136082. PubMed ID: 26287490
    [Abstract] [Full Text] [Related]

  • 2. Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis.
    Shariati A, Dadashi M, Moghadam MT, van Belkum A, Yaslianifard S, Darban-Sarokhalil D.
    Sci Rep; 2020 Jul 29; 10(1):12689. PubMed ID: 32728110
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant Staphylococcus aureus.
    Ozmen Capin BB, Tekeli A, Karahan ZC.
    Microb Drug Resist; 2020 Mar 29; 26(3):238-244. PubMed ID: 31545160
    [Abstract] [Full Text] [Related]

  • 6. Reduced vancomycin susceptibility found in methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical isolates in Northeast China.
    Hu J, Ma XX, Tian Y, Pang L, Cui LZ, Shang H.
    PLoS One; 2013 Mar 29; 8(9):e73300. PubMed ID: 24069184
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
    Khatib R, Jose J, Musta A, Sharma M, Fakih MG, Johnson LB, Riederer K, Shemes S.
    J Antimicrob Chemother; 2011 Jul 29; 66(7):1594-9. PubMed ID: 21525024
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of vancomycin use trend change due to the availability of alternative antibiotics on the prevalence of Staphylococcus aureus with reduced vancomycin susceptibility: a 14-year retrospective study.
    Kang YR, Kim SH, Chung DR, Ko JH, Huh K, Cho SY, Kang CI, Peck KR.
    Antimicrob Resist Infect Control; 2022 Aug 05; 11(1):101. PubMed ID: 35932086
    [Abstract] [Full Text] [Related]

  • 14. Molecular and Clinical Features of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus in Tertiary Care Hospitals in South India.
    Sreejisha M, Shenoy MS, Shenoy MS, Dhanashree B, Chakrapani M, Bhat KG.
    Sultan Qaboos Univ Med J; 2023 Nov 05; 23(4):447-454. PubMed ID: 38090245
    [Abstract] [Full Text] [Related]

  • 15. Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3.
    Matsuo M, Cui L, Kim J, Hiramatsu K.
    Antimicrob Agents Chemother; 2013 Dec 05; 57(12):5843-53. PubMed ID: 24018261
    [Abstract] [Full Text] [Related]

  • 16. Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia.
    Howden BP, Smith DJ, Mansell A, Johnson PD, Ward PB, Stinear TP, Davies JK.
    BMC Microbiol; 2008 Feb 27; 8():39. PubMed ID: 18304359
    [Abstract] [Full Text] [Related]

  • 17. Clinical and Microbiological Characteristics of Heteroresistant and Vancomycin-Intermediate Staphylococcus aureus from Bloodstream Infections in a Brazilian Teaching Hospital.
    da Costa TM, Morgado PG, Cavalcante FS, Damasco AP, Nouér SA, Dos Santos KR.
    PLoS One; 2016 Feb 27; 11(8):e0160506. PubMed ID: 27575698
    [Abstract] [Full Text] [Related]

  • 18. Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center.
    Lin SY, Chen TC, Chen FJ, Chen YH, Lin YI, Siu LK, Lu PL.
    J Microbiol Immunol Infect; 2012 Dec 27; 45(6):435-41. PubMed ID: 22749725
    [Abstract] [Full Text] [Related]

  • 19. Etest Methods for Screening Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) strains.
    Lee MY, Lee WI, Kim MH, Kang SY, Kim YJ.
    Curr Microbiol; 2020 Oct 27; 77(10):3158-3167. PubMed ID: 32734419
    [Abstract] [Full Text] [Related]

  • 20. High frequency of SCCmec type V and agr type I among heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in north India.
    Singh A, Prasad KN, Rahman M, Rai RP, Singh SK, Srivastava JK.
    J Glob Antimicrob Resist; 2017 Mar 27; 8():110-114. PubMed ID: 28109847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.